ABSTRACT
Rhinoscleroma is a chronic granulomatous infection of the upper respiratory tract caused by Klebsiella rhinoscleromatis . We report, to our knowledge, the first published case from Somalia. A 60‐year‐old woman presented after two years of progressive right proptosis, nasal obstruction, and headache. Magnetic resonance imaging showed an extensive right nasopharyngeal mass with orbital and intracranial extension, initially raising concern for malignancy. Biopsy demonstrated foamy Mikulicz cells and plasma cells with Russell bodies; periodic acid–Schiff staining highlighted intracytoplasmic organisms. Biopsy culture isolated K. rhinoscleromatis . The patient improved clinically after a two‐month antibiotic course, but residual fibrotic disease remained, and planned surgery was not undertaken because of financial constraints. This case illustrates how rhinoscleroma can mimic an aggressive neoplasm and how combined histopathological and microbiological assessment can establish the diagnosis despite resource limitations.
Keywords: Klebsiella rhinoscleromatis , proptosis, resource‐limited setting, rhinoscleroma, sinonasal mass, Somalia
Key Clinical Message
Rhinoscleroma remains in the differential diagnosis of a destructive sinonasal mass. Concordant biopsy culture and characteristic histopathology can distinguish this treatable chronic infection from malignancy when advanced imaging and molecular testing are unavailable.
Rhinoscleroma (First Case Reported from Somali).

1. Introduction
Rhinoscleroma is an uncommon chronic granulomatous infection caused by Klebsiella rhinoscleromatis , a Gram‐negative bacillus with tropism for the upper respiratory mucosa. The disease most often involves the nasal cavity but may extend to the nasopharynx, paranasal sinuses, larynx, trachea, and bronchi. It evolves through overlapping catarrhal, proliferative or granulomatous, and cicatricial or sclerotic phases [1, 2, 3].
The infection remains associated with crowded living conditions, limited hygiene, and delayed access to care in endemic areas of Africa, the Middle East, Asia, and Central and South America [1, 2]. Advanced proliferative disease may form a destructive‐appearing mass and resemble malignancy clinically and radiologically. Diagnosis therefore requires clinicoradiological correlation with tissue examination and, when feasible, microbiological confirmation [1, 3, 4].
We describe a culture‐confirmed case with marked orbital and intracranial extension in a patient from a remote Somali community. To our knowledge, this is the first published case from Somalia. Its value lies not in redefining a known disease, but in showing a high‐stakes diagnostic pitfall in a setting where broad ancillary pathology testing was unavailable.
2. Case History and Examination
A 60‐year‐old woman from a remote area with limited access to healthcare presented to the ophthalmology department with a two‐year history of progressive right eye protrusion, right‐sided nasal obstruction, and persistent severe headache. She also reported insomnia attributed to her symptoms. Her medical history included hypertension and diabetes mellitus. Examination showed right facial swelling and marked right proptosis. No additional systemic or laboratory findings were available in the clinical record.
3. Diagnostic Assessment
Magnetic resonance imaging of the brain and sinonasal region demonstrated a large, heterogeneously enhancing soft‐tissue mass arising from the posterior right nasopharyngeal mucosa. It extended into the right parapharyngeal and carotid spaces, masticator and parotid spaces, retro‐orbital compartment, and adjacent temporal dural region, with encasement of the carotid space and associated right otomastoiditis. The lesion displaced the globe and involved the region of the right optic nerve (Figure 1). Computed tomography was not available; consequently, cortical bone erosion and mineralization could not be characterized with the precision of CT.
FIGURE 1.

Magnetic resonance images showing a large heterogeneously enhancing mass arising from the posterior right nasopharyngeal mucosa (blue arrow), with extension into the right parapharyngeal and carotid spaces, masticator space, retro‐orbital compartment, and adjacent temporal dural region (red arrowhead). The lesion involves the region of the right optic nerve (yellow arrow) and causes ipsilateral proptosis. Associated right otomastoiditis is indicated by the green arrow.
The initial differential diagnosis prioritized nasopharyngeal carcinoma and lymphoma because of the patient's age, proptosis, and extensive infiltrative mass. Other considerations included extranodal NK/T‐cell lymphoma, rhabdomyosarcoma, Rosai–Dorfman disease, granulomatosis with polyangiitis, tuberculosis, invasive fungal infection including mucormycosis, rhinosporidiosis, leishmaniasis, and other chronic granulomatous infections. The indolent two‐year course without documented cytological evidence of malignancy supported an infectious or inflammatory mimic but did not exclude neoplasia.
An incisional biopsy showed dense chronic granulomatous inflammation with numerous large foamy macrophages (Mikulicz cells), plasma cells, and Russell bodies. Periodic acid–Schiff staining highlighted intracytoplasmic organisms within Mikulicz cells. No cytological atypia or malignant features were identified. PAS was the available special stain; Gram and Warthin–Starry stains were not performed (Figure 2). A biopsy specimen collected on 23 January 2025 yielded Klebsiella rhinoscleromatis on culture (final report, 28 January 2025). The susceptibility report classified levofloxacin, streptomycin, tetracycline, meropenem, and gentamicin as sensitive; ciprofloxacin, imipenem, and norfloxacin as intermediate; and amikacin, ceftriaxone, doxycycline, clindamycin, flucloxacillin, and oxacillin as resistant. PCR was not performed because it was unavailable. The concordant culture and characteristic histopathology established the diagnosis of rhinoscleroma.
FIGURE 2.

(A–C) Photomicrographs showing a tissue with diffuse granulomatous inflammation with numerous plasma cells and multiple, large, vacuolated macrophages under H&E stain. (D–F) Photomicrographs showing a tissue with scattered Mikulicz's cells that contain PAS positive inclusion bodies, corresponding to Klebsiella rhinoscleromatis under Periodic acid–Schiff stain.
4. Therapeutic Intervention and Outcome
The patient received ciprofloxacin 500 mg orally every 12 h and tetracycline 500 mg orally every 6 h, both for eight weeks. Tetracycline eye ointment was also used. The patient experienced marked reduction in proptosis and improved sleep. Antibiotic treatment was discontinued after completion of the planned eight‐week course and clinical improvement; microbiological eradication was not documented by repeat culture.
Because residual fibrotic tissue remained, multidisciplinary surgical debulking or excision was proposed to relieve obstruction and address fixed cicatricial disease. The patient did not proceed because of financial constraints. Endoscopic surveillance, repeat culture, susceptibility‐guided treatment if active disease persisted or recurred, and reassessment for surgery were advised.
5. Discussion
This case demonstrates a clinically important mimic of an aggressive sinonasal neoplasm. The extensive mass, orbital displacement, and apparent intracranial extension reasonably raised concern for nasopharyngeal carcinoma or lymphoma. Yet the prolonged course and tissue findings pointed to chronic infection. The diagnostic conclusion was strengthened by isolation of K. rhinoscleromatis from the biopsy, addressing the limited specificity of morphology alone. Culture sensitivity is imperfect and may vary by disease stage, while PCR can improve organism detection where available; in this setting, PCR could not be performed [1, 3].
The differential diagnosis of a destructive sinonasal lesion is broad. Nasopharyngeal carcinoma and lymphoma may present with an infiltrative mass but would be expected to show malignant cells on adequate biopsy. Extranodal NK/T‐cell lymphoma often produces angiocentric necrosis and requires immunophenotyping and Epstein–Barr virus testing. Granulomatosis with polyangiitis may cause midline destruction but is characterized histologically by necrotizing granulomatous inflammation and vasculitis and requires clinical and serological correlation. Tuberculosis, leprosy, syphilis, actinomycosis, leishmaniasis, rhinosporidiosis, histoplasmosis, and mucormycosis may also produce chronic granulomatous or destructive lesions. Rosai–Dorfman disease can contain large histiocytes but typically shows emperipolesis rather than intracellular bacilli [1, 4, 5]. In this patient, Mikulicz cells, Russell bodies, PAS‐positive intracytoplasmic organisms, absence of malignant atypia, and a concordant tissue culture favored rhinoscleroma.
Histopathological findings vary with stage. The proliferative phase is characterized by Mikulicz cells containing organisms and plasma cells with Russell bodies; progressive fibrosis and stenosis dominate the cicatricial phase [1, 3]. The combination of a bulky infiltrative lesion and residual fixed tissue after medical improvement suggests overlapping proliferative and cicatricial disease rather than a purely sclerotic stage. PAS supported organism visualization, but the absence of Gram and Warthin–Starry staining is an acknowledged limitation. Culture confirmation provides independent microbiological support.
Cross‐sectional imaging defines extent and complications. MRI was particularly useful for soft‐tissue, orbital, skull‐base, and dural assessment. CT would have better delineated cortical bone erosion and remodeling, but it was not available and no CT findings are claimed. This limitation is clinically relevant: in resource‐constrained settings, diagnosis may depend on the integration of MRI, biopsy morphology, and culture rather than a complete multimodal work‐up.
There is no universally standardized antibiotic regimen because evidence is based mainly on case series and case reports. Prolonged treatment is commonly recommended, with published durations ranging from approximately two months to one year, and antibiotic selection should be guided by susceptibility results, clinical response, disease stage, and feasibility [2, 6]. Fluoroquinolones, tetracyclines, rifampicin, co‐trimoxazole, and aminoglycosides have been used. Surgery is reserved for airway compromise, obstruction, deformity, or persistent fibrotic tissue and should generally accompany antimicrobial therapy when active infection is present [2, 6].
Interpretation of the antimicrobial record requires caution. The susceptibility report classified ciprofloxacin as intermediate and tetracycline as sensitive, although the documented regimen comprised ciprofloxacin 500 mg orally every 12 h and tetracycline 500 mg orally every 6 h for eight weeks. The observed clinical improvement does not resolve this in vitro–clinical discordance and does not prove microbiological eradication. Repeat culture and prolonged follow‐up would be important because relapse can occur. Any subsequent treatment should be guided by a current culture and susceptibility test, individual contraindications, disease activity, and specialist review [1, 2].
The novelty of this report is contextual and educational. To our knowledge, it is the first published Somali case and documents how geographic underreporting, delayed presentation, limited imaging, and restricted molecular and histochemical testing can amplify diagnostic uncertainty. It also shows that a treatable infection should be considered before radical oncological surgery for a destructive sinonasal mass.
6. Conclusion
Rhinoscleroma should be considered when a chronic destructive sinonasal mass resembles malignancy, particularly in patients from endemic or underserved settings. In this Somali patient, characteristic histopathology and biopsy culture established the diagnosis despite the unavailability of CT and PCR. Culture susceptibility should guide prolonged antimicrobial therapy, while surgery may be required for persistent obstructive or cicatricial disease. Careful follow‐up is essential because clinical improvement alone does not establish eradication.
Author Contributions
Mohamed Ali Kahiye: conceptualization, methodology, investigation, funding acquisition, formal analysis, writing – original draft, writing – review and editing. Shuayb Moallim Ali: writing – original draft, investigation. Faisal Abdi Osoble Osman: supervision, writing – original draft, writing – review and editing. Yahye Garad Mohamed: investigation. Jamal Saman: writing – original draft.
Funding
The authors have nothing to report.
Ethics Statement
The case was managed and reported in accordance with the principles of the Declaration of Helsinki. Sahan Pathology Labs waived formal ethics committee approval because this publication describes a single patient and did not constitute human‐subjects research. Written informed consent for publication was obtained from the patient.
Consent
Written informed consent was obtained from the patient for publication of the clinical details and accompanying images.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
Use of Artificial Intelligence: Generative artificial intelligence tools were used solely to assist with language editing, grammatical refinement, and improvement of manuscript clarity. All AI‐assisted content was critically reviewed, verified, and revised by the authors. The authors take full responsibility for the accuracy, integrity, originality, and scientific content of the final manuscript.
Data Availability Statement
Data supporting this case report are available from the corresponding author upon reasonable request, subject to patient confidentiality and institutional requirements.
References
- 1. Umphress B. and Raparia K., “Rhinoscleroma,” Archives of Pathology & Laboratory Medicine 142, no. 12 (2018): 1533–1536, 10.5858/arpa.2018-0073-RA. [DOI] [PubMed] [Google Scholar]
- 2. de Pontual L., Ovetchkine P., Rodriguez D., et al., “Rhinoscleroma: A French National Retrospective Study of Epidemiological and Clinical Features,” Clinical Infectious Diseases 47, no. 11 (2008): 1396–1402, 10.1086/592966. [DOI] [PubMed] [Google Scholar]
- 3. Ahmed A. R., El‐Badawy Z. H., Mohamed I. R., and Abdelhameed W. A., “Rhinoscleroma: A Detailed Histopathological Diagnostic Insight,” International Journal of Clinical and Experimental Pathology 8, no. 7 (2015): 8438–8445. [PMC free article] [PubMed] [Google Scholar]
- 4. Botelho‐Nevers E., Gouriet F., Lepidi H., et al., “Chronic Nasal Infection Caused by Klebsiella rhinoscleromatis or Klebsiella ozaenae : Two Forgotten Infectious Diseases,” International Journal of Infectious Diseases 11, no. 5 (2007): 423–429, 10.1016/j.ijid.2006.10.005. [DOI] [PubMed] [Google Scholar]
- 5. Poniatowski P., Łuczak K., and Nelke K., “Difficulties in Diagnosing and Treating Nasal Rhinoscleroma: A Case Study,” Dental and Medical Problems 54, no. 4 (2017): 435–439, 10.17219/dmp/76848. [DOI] [Google Scholar]
- 6. Al Jahdali H., Bamefleh H., Memish Z., Al‐Zuwayed M., and Al Othman A., “Upper Airway Obstruction due to Rhinoscleroma: Case Report,” Journal of Chemotherapy 13, no. 1 (2001): 6–72. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data supporting this case report are available from the corresponding author upon reasonable request, subject to patient confidentiality and institutional requirements.
